- Short report
- Open Access
Lnc-DC regulates cellular turnover and the HBV-induced immune response by TLR9/STAT3 signaling in dendritic cells
Cellular & Molecular Biology Letters volume 23, Article number: 43 (2018)
Lnc-DC is a specific group of long non-coding (Lnc) RNAs in dendritic cells (DCs). Its function has been previously studied, and includes roles in dendritic cell differentiation and the progression of some diseases. In this study, we observed the critical role of Lnc-DC in regulating the differentiation, growth, and apoptosis of dendritic cells.
We first isolated peripheral blood mononuclear cells to culture and induce into DCs, which were then co-cultured with hepatitis B virus (HBV)-secreting HepG2.2.15 cells for the detection of changes in Lnc-DC. The expression levels of TLR9, p-STAT3, and SOCS3 were tested with qPCR and western blot. MTT assays were used to analyze the cell proliferation, cell cycle, and apoptosis. We used ELISA to test the expression of TNF-α, IL-1β, IL-6, IL-12p40, and IFN-γ.
Co-culture with HBV-secreting HepG2.2.15 cells increased the level of Lnc-DC and activated TLR9/STAT3 signaling. The HBV DNA level (IU/ml) was positively correlated with levels of Lnc-DC and TLR9, further demonstrating that Lnc-DC was associated with the immune response of HBV. Lnc-DC was shown to regulate TLR9/STAT3 signaling in dendritic cells. More interestingly, the regulation of Lnc-DC controlled the immune response by reducing the concentration of secreted TNF-α, IL-6, IL-12, and IFN-γ, as well as increasing the IL-1β concentration in dendritic cells.
Lnc-DC is important in regulating the growth, apoptosis, and immune response of dendritic cells mediated by TLR9/STAT3 signaling, and was also activated by HBV. This study provides a previously unidentified mechanism underlying the immune response in dendritic cells.
Long non-coding RNAs (Lnc-RNAs) are a type of regulatory RNA less than 200 nt in length with no protein-coding functions. One specific Lnc-RNA in dendritic cell (DC) is Lnc-DC. Knockdown of Lnc-DC has been shown to impair DC differentiation in human monocytes . The role of Lnc-DC in the regulation of STAT3 signaling was recently elucidated in coronary artery disease and type 2 diabetes mellitus . In systemic lupus erythematosus, plasma Lnc-DC was identified as a novel biomarker . Lnc-DC overexpression induced the over-maturation of decidual dendritic cells in preeclampsia patients and led to an increase in Th1 cells . All these findings demonstrate the critical role of Lnc-DC in disease occurrence and progression.
Lnc-DC is located on chromosome 17, near the STAT3 gene. Its regulation on STAT3 signaling has been previously reported. Lnc-DC binds to STAT3, prevents dephosphorylation, and stimulates tyrosine phosphorylation . Phosphorylation of STAT3 is crucial for signaling activation and nuclear translocation . This results in overexpression of target genes and the regulation of cell growth, differentiation, and migration.
Toll-like receptor 9 (TLR9) is well expressed in immune cells. The correlation of TLR9 and STAT3 was elucidated in several cellular types. For example, STAT3 signaling is targeted by TLR9, thereby affecting the immunosuppressive activity of myeloid-derived suppressor cells . TLR9 and STAT3 have a synergic effect on promoting the tumor propagation potential of prostate cancer cells . Meanwhile, TLR9 activation induced an anti-inflammatory response in macrophages through the STAT3-dependent pathway .
In these lines, we studied the role of Lnc-DC in the growth, apoptosis and HBV-induced immune response of dendritic cells. Growth was inhibited and apoptosis was promoted in dendritic cells after Lnc-DC knockdown. The immune response was negatively regulated with Lnc-DC knockdown. In addition, we found that Lnc-DC knockdown reduced the expression levels of pSTAT3, TLR9, and SOCS3, demonstrating the involvement of TLR9/STAT3 signaling. The hepatitis B virus (HBV) DNA level was regulated by Lnc-DC and TLR9 signaling in dendritic cells. Therefore, this work elucidated the role of Lnc-DC in dendritic cell growth and the immune response, potentially identifying a new mechanism underlying the correlation between Lnc-DC and the immune response in HBV infection.
Materials and methods
Isolation of peripheral blood mononuclear cells
Human peripheral blood mononuclear cells (PBMCs) were prepared as previously described . PBMCs were isolated from 10 mL of venous blood using a Ficoll-Paque PLUS centrifuge as previously described . After centrifugation, cells were collected from the interphase layer and washed four times with RPMI 1640 medium. PBMCs (1 × 107 cells/mL) were suspended in RPMI 1640 supplemented with 10% (v/v) and FBS was used to induce the generation of dendritic cells.
Isolation of primary monocytes from PBMCs
Monocytes from Ficoll-isolated PBMCs were resuspended in PBS and incubated in CD14 microbeads for 15 min at 4 °C. The microbead-labeled cells were then resuspended in PBS after centrifugation and isolated by an MS column. The cells labeled with microbeads were washed from the column with PBS; the resultant cells were CD14+ monocytes.
Induction of dendritic cells from monocytes
Dendritic cells were generated from monocytes in the presence of GM-CSF (50 ng/ml) and IL-4 (100 ng/ml). The cells were cultured for six days in RPMI1640 growth medium supplemented with 10% FBS. Maturation of dendritic cells was promoted with stimulation by 1 μg/ml LPS for 24 h.
Cell-surface molecule expression of the cultured dendritic cells was evaluated by flow cytometry (FC500, Beckman Coulter), using the following fluorochrome-labeled antibodies: mouse anti-human CD86 FITC (BD Pharmingen) and mouse anti-Human CD83 APC (eBioscience). CXP software from Beckman Coulter was used for the analyses.
Co-culture of HepG2.2.15 and dendritic cells
The co-culture of HepG2.2.15 and dendritic cells was conducted in a transwell system (Corning). HepG2.2.15 cells were seeded in plate and dendritic cells were grown in inserts. The ratio of HepG2.2.15 to dendritic cells was 2.8:1. Both were maintained in RPMI1640 medium supplemented with 10% FBS.
Total RNA extraction was performed using TRIzol reagent (Life Technologies) according to the manufacturer’s instructions. Two micrograms of total RNA extracted from dendritic cells was subjected to reverse transcription (RT). The cDNA was synthesized using a one-step RT-PCR kit from Takara. SYBR Green (Toyobo) RT-PCR amplification and real-time fluorescence detection were performed using an ABI 7300 real-time PCR thermal cycle instrument (ABI, USA), according to the supplied protocol. The relative gene expression was calculated by the ∆∆Ct method and the relative expression levels were normalized to that of endogenous GAPDH. The primers used were as follows: H-TLR9-F: CGGTTTGATCTGGCTGGACT, H-TLR9-R: AGGCCAGGTAATTGTCACGG; H-SOCS3-F: TGGTCACCCACAGCAAGTTT, H-SOCS3-R CTGTCGCGGATCAGAAAGGT; and Lnc-DC-F: CAGCCTTCCTCCTCCTGTGA, Lnc-DC-R: CAGCCTTCCTCCTCCTGTGA.
A total of 2 μg of cell lysate was loaded into each lane of a 10% polyacrylamide gel, then blotted onto a polyvinylidene difluoride (PVDF) membrane. After blocking with PBST containing 5% nonfat dry milk, the membrane was incubated with specific primary antibodies against p-Stat3, Stat3, TLR9, and SOCS3. All antibodies were purchased from Cell Signaling Technologies. Peroxidase-linked IgG (Life Technologies) was used as the secondary antibody. These proteins were visualized with an ECL western blotting detection kit (Amersham Biosciences).
Viral production and infection
A lentivirus expressing Lnc-DC-shRNA (shLnc-DC) was produced and purified using the BLOCK-iT Inducible H1 Lentiviral RNAi System (Life Technologies). An shRNA with a scramble sequence was used to generate the control virus. All the manufacturer’s procedures were strictly followed. Dendritic cells in each well were infected with 2 × 106 pfu of virus. The analysis was conducted three days after infection.
MTT was used to evaluate the proliferation of dendritic cells after the downregulation of Lnc-DC. Briefly, cells were incubated with MTT for at least 4 h to produce formazan. When the formazan was completely dissolved by SDS-HCl, the absorbance was measured at 570 nm with a Universal Microplate Reader (Bio-Tek instruments), and OD (MLB-treated group)/OD (blank control group) was calculated.
Analysis of cell cycle phase by flow cytometry
Forty-eight hours following infection with lenti-shLnc-DC, dendritic cells were resuspended in PBS twice before fixation by dropwise addition to 95% precooled ethanol. Prior to analysis, the cells were warmed, centrifuged at 450 g for 5 min, resuspended twice in PBS, then stained with propidium iodide PI (containing RNase A at 50 μg/ml) at room temperature in the dark for 30 min. The DNA content was analyzed by flow cytometry using the CellQuest program (Becton-Dickinson).
Annexin V/7-AAD staining
Cells were washed twice with staining buffer, and then resuspended in Annexin V binding buffer. FITC-Annexin V and the 7-AAD staining solution were added and incubated with cells for 15 min at room temperature in the dark. We used 488 nm excitation and measured the fluorescence emission near 530 nm (FITC channel) for Annexin V and > 670 nm (PE channel) for 7-AAD by flow cytometry.
Enzyme-linked immunosorbent assay
The inflammatory factors in the cell culture supernatant after Lnc-DC silencing were detected by an ELISA kit with quantitative measurements, according to the manufacturer’s recommendations. The inflammatory factors included TNF-α, IL-1β, IL-6, IL-12, and IFN-γ (CUSABIO).
All data were presented as mean ± SD. The band density in the western blot analysis was measured with Image J software (NIH). Statistical significance was determined by unpaired Student’s t-test using SigmaPlot Software (Systat Software, San Jose, CA, USA). A value of p < 0.05 was considered to be significant.
Coculture of dendritic and HepG2.2.15 cells activated TLR/STAT3 signaling
Dendritic cells were induced from PBMCs and characterized by flow cytometry against CD83 and CD86 (Fig. 1a, b). After coculture with HepG2.2.15 cells, TLR/STAT3 signaling was activated, as evidenced by quantitative real-time PCR demonstrating that the Lnc-DC, SOCS3, and TLR9 mRNA levels increased (Fig. 1c, d and e). The activation of TLR/STAT3 signaling was confirmed by western blotting, in that the levels of p-STAT3, TLR9, and SOCS3 increased in dendritic cells cocultured with HepG2.2.15 cells (Fig. 1f, g, h, i and j). Thus, TLR/STAT3 signaling was activated in dendritic cells when cocultured with cells secreting HBV.
Silencing Lnc-DC regulated TLR/STAT3 signaling in dendritic cells
Next, we measured the correlations among Lnc-DC, HBV, and TLR9 in the PBMCs of six different groups: non-infected people, infected people in the immunotolerant phase, infected people in the immune clearance phase, infected people in the recovery phase, infected people in the relapse phase, and infected people with hepatitis B cirrhosis. The mRNA levels of Lnc-DC and TLR9 were positively correlated with the level of HBV DNA (Fig. 2a). In order to elucidate the role of Lnc-DC in dendritic cells, cells were infected with lenti-shRNA-Lnc-DC. The Lnc-DC mRNA level was reduced to ~ 50% of that of the control group, showing the efficiency of lenti-shRNA-Lnc-DC (Fig. 2b). With the downregulation of Lnc-DC, the mRNA level of TLR9 and SOCS3 significantly decreased (Fig. 2c, and d, p < 0.01). Similarly, western blotting indicated that the levels of p-STAT3, TLR9, and SOCS3 decreased in shLnc-DC infected dendritic cells (Fig. 2e, f, g, h, and i, p < 0.01). This indicates that Lnc-DC regulated TLR/STAT3 signaling in dendritic cells.
Silencing of Lnc-DC affected dendritic cell proliferation
Next, we determined whether Lnc-DC downregulation affected the proliferation of dendritic cells. An MTT assay indicated that Lnc-DC downregulation could impair the proliferation of dendritic cells (Fig. 3a). To further demonstrate whether or not the expression of Lnc-DC regulated dendritic cell death, we analyzed the alteration to the cell cycle in correlation with the downregulation of Lnc-DC. The cell cytometry analysis showed that the ratio of cells at S or G2/M phase decreased while the ratio of cells at G1 phase increased (Fig. 3b, and c). This indicated that Lnc-DC downregulation arrested fewer dendritic cells at G1 phase. 7-AAD/Annexin V staining showed that the ratio of apoptotic cells was significantly increased in the shLnc-DC group (p < 0.01, Fig. 3d, e and f). These data demonstrate that Lnc-DC regulated the proliferation and apoptosis of dendritic cells.
Lnc-DC silencing regulated the immune response in dendritic cells
Since inflammation is an important feature of dendritic cells, we asked whether Lnc-DC silencing could affect the immune response. The ELISA data indicate that Lnc-DC silencing significantly decreased the concentration of TNF-α (p < 0.001, Fig. 4a). Similarly, we also observed a reduction in the concentration of IL-6 (p < 0.01, Fig. 4b), IL-12 (p < 0.05, Fig. 4c), and IFN-γ (p < 0.01, Fig. 4d). The decrease of IL-6 in the shLnc-dc group was minimal. By contrast, we observed a drastic increase in the concentration of IL-1β with the downregulation of Lnc-DC (Fig. 4e). In summary, these data show that Lnc-DC can regulate inflammation in dendritic cells.
In this study, we demonstrated the role of Lnc-DC in regulating the growth, apoptosis, and immune response in dendritic cells through TLR9/STAT3 signaling. HBV DNA was also associated with TLR9/STAT3 signaling. Therefore, we proposed a new mechanism underlying the cellular turnover in dendritic cells and the immune response by HBV.
One interesting finding of our study was that the co-culture of HepG2.215 and dendritic cells activated TLR9/STAT3 signaling and the expression level of TLR9 was positively correlated with HBV DNA in PBMCs from hepatitis B patients. HepG2.215 is a human hepatic cell line that has been widely used in HBV production for antiviral research . Thus, the activation of TLR9/STAT3 signaling in the co-culture system indicated that HBV induced TLR9/STAT3 signaling. The stimulation of dendritic cells leads to a boost in endogenous T-cell immunity. Nevertheless, the effect of HBV on dendritic cells is still not clear . The exhaustion of chronic HBV-specific T cells makes it difficult to boost HBV-specific T-cell immunity and the action of HBV on dendritic cells is difficult to understand. Many studies have shown that inflammatory cytokines are involved in the immune response. For example, IL-1 was proven to support the activation of immune response induction . IL-6 and TGF-β participate in immune regulation of dendritic cells . Thus, we detected the concentrations of IL-1β, TNF-α, IL-6, IL-12, and IFN-γ. The decreased concentrations of these inflammatory cytokines showed that Lnc-DC may play a significant role in the regulation of the immune response. More interestingly, the concentration of IL-1β increased when Lnc-DC was inhibited, the reasons for which can be explored in the future. Through this study, we linked HBV-infected dendritic cells via Lnc-DC regulation with TLR9/STAT3 signaling. This is the first piece of evidence to show the role of Lnc-RNAin the HBV-induced immune response of dendritic cells, as well as its underlying mechanism. However, we did not identify the subtypes of dendritic cells in which HBV led to the activation of TLR9/STAT3 signaling [15,16,17]. In order to more accurately describe the correlation between dendritic cells, Lnc-DC, and HBV, characterization of dendritic cells will be a future research direction. In addition, the mechanisms by which HBV increases the expression of Lnc-DC should also be further studied.
We found that Lnc-DC regulated TLR9/STAT3 signaling in dendritic cells. The correlation between Lnc-RNAs and STAT3 signaling has been described in multiple tumor cells [18,19,20]. In this study, we elucidated the role of Lnc-DC in dendritic cells mediated by TLR9/STAT3 signaling. Lnc-DC knockdown induced inactivation of TLR9/STAT3, which led to decreased proliferation and increased apoptosis. This potentially indicates that an alteration of cellular turnover in dendritic cells is due to TLR9/STAT3 inactivation. Thus, the downstream effects of TLR9/STAT3 need to be investigated to reveal the underlying mechanism. ERK signaling is a potential downstream effector in controlling the immune response mediated by TLR9/STAT3 . This may also be associated with inactivation of NF-κB signaling and activation of apoptotic pathways. All of these need to be further investigated.
This study investigated the immune response mechanism of Lnc-DC, and the findings suggest that TLR9/STAT3 signaling participates in the immune response, which was activated by HBV. This study identifies a previously unidentified mechanism underlying the immune response in dendritic cells.
Hepatitis B virus
Long non-coding RNAs
Peripheral blood mononuclear cells
Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S, Jiang Z, Xu J, Liu Q, Cao X. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science. 2014;344:310–3.
Alikhah A, Pahlevan Kakhki M, Ahmadi A, Dehghanzad R, Boroumand MA, Behmanesh M. The role of lnc-DC long non-coding RNA and SOCS1 in the regulation of STAT3 in coronary artery disease and type 2 diabetes mellitus. J Diabetes Complicat. 2018;32:258–65.
Wu GC, Li J, Leng RX, Li XP, Li XM, Wang DG, Pan HF, Ye DQ. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus. Oncotarget. 2017;8:23650–63.
Zhang W, Zhou Y, Ding Y. Lnc-DC mediates the over-maturation of decidual dendritic cells and induces the increase in Th1 cells in preeclampsia. Am J Reprod Immunol. 2017;77.
Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82:241–50.
Hossain DM, Pal SK, Moreira D, Duttagupta P, Zhang Q, Won H, Jones J, D'Apuzzo M, Forman S, Kortylewski M. TLR9-targeted STAT3 silencing abrogates immunosuppressive activity of myeloid-derived suppressor cells from prostate Cancer patients. Clin Cancer Res. 2015;21:3771–82.
Moreira D, Zhang Q, Hossain DM, Nechaev S, Li H, Kowolik CM, D'Apuzzo M, Forman S, Jones J, Pal SK, Kortylewski M. TLR9 signaling through NF-kappaB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells. Oncotarget. 2015;6:17302–13.
Hsu K, Chung YM, Endoh Y, Geczy CL. TLR9 ligands induce S100A8 in macrophages via a STAT3-dependent pathway which requires IL-10 and PGE2. PLoS One. 2014;9:e103629.
Emi N, Kanzaki H, Yoshida M, Takakura K, Kariya M, Okamoto N, Imai K, Mori T. Lymphocytes stimulate progesterone production by cultured human granulosa luteal cells. Am J Obstet Gynecol. 1991;165:1469–74.
Hashii K, Fujiwara H, Yoshioka S, Kataoka N, Yamada S, Hirano T, Mori T, Fujii S, Maeda M. Peripheral blood mononuclear cells stimulate progesterone production by luteal cells derived from pregnant and non-pregnant women: possible involvement of interleukin-4 and interleukin-10 in corpus luteum function and differentiation. Hum Reprod. 1998;13:2738–44.
Sun D, Nassal M. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol. 2006;45:636–45.
Gehring AJ, Ann D'Angelo J. Dissecting the dendritic cell controversy in chronic hepatitis B virus infection. Cell Mol Immunol. 2015;12:283–91.
Marhaba R, Nazarenko I, Knöfler D, Reich E, Voronov E, Vitacolonna M, Hildebrand D, Elter E, Apte RN, Zöller M. Opposing effects of fibrosarcoma cell-derived IL-1 alpha and IL-1 beta on immune response induction. Int J Cancer. 2008;123:134.
Keswani T, Sarkar S, Sengupta A, Bhattacharyya A. Role of TGF-β and IL-6 in dendritic cells, Treg and Th17 mediated immune response during experimental cerebral malaria. Cytokine. 2016;88:154–66.
Zhang Z, Chen D, Yao J, Zhang H, Jin L, Shi M, Zhang H, Wang FS. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B. Clin Immunol. 2007;122:173–80.
Beckebaum S, Cicinnati VR, Dworacki G, Muller-Berghaus J, Stolz D, Harnaha J, Whiteside TL, Thomson AW, Lu L, Fung JJ, Bonham CA. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol. 2002;104:138–50.
Tavakoli S, Schwerin W, Rohwer A, Hoffmann S, Weyer S, Weth R, Meisel H, Diepolder H, Geissler M, Galle PR, et al. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol. 2004;85:2829–36.
Xue J, Liao L, Yin F, Kuang H, Zhou X, Wang Y. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway. Cancer Biomark. 2018;21:1-10.
Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu DY, Tang CJ, De W, Yang F. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer. 2018;17:6.
Li S, Mei Z, Hu HB. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis. J Cell Physiol. 2018;233(9):6679–88.
Liu BS, Cao Y, Huizinga TW, Hafler DA, Toes RE. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 2014;44:2121–9.
This study was supported by the Science and Technology Planning Project of Shenzhen Municipality (JCYJ20150402152005629).
Availability of data and materials
The datasets used or analyzed during this study are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhuang, L., Tian, J., Zhang, X. et al. Lnc-DC regulates cellular turnover and the HBV-induced immune response by TLR9/STAT3 signaling in dendritic cells. Cell Mol Biol Lett 23, 43 (2018). https://doi.org/10.1186/s11658-018-0108-y
- Dendritic cell